We are a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on ...
Investor Relations · Events & Presentations · Event Calendar · Upcoming Events · Featured Presentation · Featured Webinar · Archived Events & Presentations.
Nov 6, 2023 · This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain “forward-looking ...
Mar 7, 2024 · ... CDXC) Q4 2023 Earnings Call Transcript March 6, 2024 ChromaDex ... investor relations section of ChromaDex's website at www.ChromaDex.com.
Feb 21, 2024 · ChromaDex management will host an investor conference call to discuss fourth quarter 2023 results and provide a general business update on ...
20 hours ago · kendall.knysch@chromadex.com. ChromaDex Investor Relations Contact: +1 (949) 356-1620 InvestorRelations@ChromaDex.com. Author.
Mar 7, 2024 · The webcast will be available at the Investor Relations section of our website at www.chromadex.com. With that, it is now my pleasure to turn ...
Mar 17, 2023 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Jan 26, 2024 · 26, 2024-- ChromaDex Corp . (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, today ...
Find the latest institutional holdings data for ChromaDex Corporation Common Stock (CDXC) including shareholders, ownership summaries, ...
